Vor Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -28 | -23 | ||
EBITDA | -47,853 | -219,557 | 1,722,881 | -812,682 |
EBIT | -219,585 | 1,722,858 | -812,684 | |
Net Income | -62,810 | -219,585 | 1,722,858 | -812,684 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -25,794 | -38,294 | -23,115 | -53,906 |
Cash | 107,855 | 169,873 | 396,486 | 160,462 |
Basic Shares | 54,304 | 430 | 9,871 | 6,681 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,528 | -3,492 | -8,960 | |
EBITDA | -693,094 | -113,386 | -114,371 | -83,134 |
EBIT | -695,981 | -116,914 | -117,863 | -92,094 |
Net Income | -695,981 | -116,914 | -117,863 | -92,094 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -62,095 | |||
Free Cash Flow | -143,654 | -99,889 | -101,361 | -93,606 |
Cash | 396,486 | 81,949 | 31,360 | 57,706 |
Basic Shares | 9,871 | 3,435 | 3,359 | 1,977 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.80 |
2026-03-31 | -$0.73 |
2025-12-31 | $307.53 |
2025-09-30 | -$121.63 |